CIPHER
What CIPHER does
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) closes scientific gaps by placing the unique challenges of paediatric and adolescent populations on the global public health agenda.
Established in 2012, CIPHER accelerates an evidence-informed, human rights-based and integrated HIV response for infants, children, adolescents and young people living with and affected by HIV.
CIPHER in context
A child (aged 0-14 years) dies from AIDS-related causes every seven minutes. In 2024, 55% of children living with HIV received antiretroviral therapy compared with 77% of adults, well short of the global target of 95% treatment coverage.
CIPHER was the domino effect that propelled so many good things in my life, and I’m so grateful.
CIPHER Research Grantee 2018 - Wipaporn Natalie Songtaweesin, Thailand
CIPHER in action
CIPHER:
- Addresses major scientific gaps by building the next generation of scientists and leaders in paediatric and adolescent HIV research and programming
- Accelerates the translation of evidence into policies, programmes and care
- Uses evidence to spotlight critical issues for children, adolescents and young people in the HIV response
Key numbers
65
change makers supported through CIPHER Grants and Fellowships since 2012
Over 200
CIPHER-funded publications on paediatric and adolescent HIV research published
12
symposia convened on children and adolescents with perinatal HIV exposure
Upcoming activities
- CIPHER Research Grant Programme – This programme awards early-stage investigators up to USD 140,000 over two years to address research gaps in paediatric and adolescent HIV in countries with limited resources for HIV research. It is designed to provide investigators with the experience they need to compete for larger funding.
Contact
IAS 2025 Pre-Conference – 11th symposium on children and adolescents with perinatal HIV exposure
In partnership with
